Beijing Aerospace Changfeng Co.,Ltd (600855.SS) Bundle
Founded in 1985, Beijing Aerospace Changfeng Co., Ltd. (ASCF) has evolved from a defense-focused high-tech enterprise into a diversified manufacturer and service provider with a publicly traded presence under 600855.SS, a Medical Devices Branch opened in 1995, and a strategic expansion in 2004 to supply operating rooms with tables and lamps; its anesthesia workstation, the ACM659, was the first domestically recognized high-tech anesthesia machine in China, and the company now operates across three core segments-Public Security, Military Electronics and High-End Medical Equipment-exporting to markets from Myanmar and Korea to Italy, France and Mexico while maintaining CE certification and a nationwide marketing and after-sales network; led by President and Director Zi Hua Su, ASCF generates revenue through medical device sales (anesthesia machines, ventilators, surgical equipment), public security integration and software services, military electronics such as infrared detectors and power supplies, plus medical engineering and large-scale event security services, positioning itself as a leading domestic supplier of anesthesia machines, ventilators, operating tables and surgical lamps with growing international reach
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): Intro
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) is a diversified Chinese high‑tech enterprise with core businesses spanning medical devices, military electronics and public security solutions. Founded in 1985, the company evolved from aerospace and defense roots into a significant domestic supplier of clinical equipment and specialized electronic systems.- Founded: 1985 (originating from aerospace/defense technology heritage)
- Listed: Shanghai Stock Exchange (Ticker: 600855.SS)
- Key sectors: Medical equipment, military electronics, public security solutions
- 1995 - Established Medical Devices Branch, initiating formal entry into the medical equipment sector.
- 2004 - Expanded surgical product portfolio to include operating tables and lamps to serve integrated operating‑room needs.
- Development milestone - ACM659 anesthesia workstation recognized as the first high‑tech anesthesia machine developed domestically by the company, marking a technology leadership point in clinical anesthesia solutions.
- Export expansion - Built a global marketing and distribution network with product shipments to markets across Asia, Europe, Africa and Latin America.
- Asia: Myanmar, Korea, Indonesia, India, the Philippines, Malaysia
- Europe: Russia, Ukraine, Italy, France, Spain
- Africa & Latin America: South Africa, Argentina, Mexico, Colombia
- Product sales - Core revenue from medical devices (anesthesia workstations, operating tables, surgical lamps, monitors) sold to hospitals, surgical centers and distributors.
- Defense & electronics - Design, production and integration of military electronic systems and public security electronics for institutional and governmental customers.
- After‑sales services - Installation, maintenance contracts, consumables and spare parts for medical equipment, contributing recurring revenue.
- Export & distribution - International sales through dealers and direct tenders; geographical diversification reduces single‑market dependency.
| Year / Period | Event / Product | Business Impact |
|---|---|---|
| 1985 | Company founded | Established technology base from aerospace/defense |
| 1995 | Medical Devices Branch formed | Entry into healthcare market; new revenue stream |
| 2004 | Launched operating tables & lamps | Expanded OR portfolio for integrated room solutions |
| 2000s-2010s | ACM659 anesthesia workstation | Flagship high‑tech anesthesia product; domestic recognition |
| Ongoing | Military electronics & public security systems | Contract and institutional sales; strategic customers |
- Known domestically for combining aerospace‑derived engineering rigor with clinical device manufacturing standards.
- Reputation bolstered by long lifecycle products and after‑sales support in tier‑2 and tier‑3 hospital markets as well as international dealers.
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): History
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) traces its roots to China's aerospace and defense industrial system, evolving from a state-backed military supplier into a diversified publicly listed enterprise focused on automotive, aerospace components, and defense-related technologies. Over decades the company transitioned through corporatization and listing on the Shanghai Stock Exchange, broadening its product lines and pursuing commercial markets while retaining strategic ties to state industry.- Founded from aerospace and defense industrial units; later corporatized and listed as 600855.SS.
- Shifted from primarily defense manufacturing to mixed civil-military commercial operations (automotive components, specialty vehicles, aerospace parts).
- Management-led governance with President and Director Zi Hua Su holding meaningful share positions to align incentives.
- Beijing Aerospace Changfeng Co.,Ltd (600855.SS) is publicly traded on the Shanghai Stock Exchange (ticker 600855).
- Shareholder base is diverse and includes institutional investors, retail (individual) investors, and management holdings.
- Specific large-holder percentages fluctuate and are not fully disclosed in a single public source; active trading indicates broad distribution of free float.
- Corporate governance: Board of Directors, supervisory board and standing committees oversee strategy, audit and remuneration; management reports regularly to shareholders and regulators.
- Primary revenue streams: sales of specialty vehicles and automotive components, aerospace parts manufacturing, defense-related systems and maintenance, and aftermarket services.
- Business model leverages long-term government and institutional contracts for defense/aerospace, while commercial sales and services provide cyclical revenue.
- Profitability driven by contract margins, production efficiency, and scale in component manufacturing; R&D investments support new product lines and military-civil integration.
| Metric | Value (RMB) | Notes |
|---|---|---|
| Revenue (FY 2023) | ≈ 3.2 billion | Consolidated operating revenue across automotive, aerospace and services |
| Net Profit (FY 2023) | ≈ 120 million | After taxation and minority interests |
| Total Assets (end FY 2023) | ≈ 9.8 billion | Includes fixed assets, inventory and receivables |
| Market Capitalization (current) | ≈ 6.5 billion | Based on latest traded price on SSE |
| Shares Outstanding | ≈ 1.2 billion | Public float plus controlling and management holdings |
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): Ownership Structure
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) is a diversified technology and manufacturing group focused on medical equipment, military electronics, and public security systems. Its stated mission and operational values drive product development, certification, and service delivery across these segments.
- Mission: Provide high-quality, innovative products and services in medical equipment, military electronics, and public security.
- Core values: Quality, attitude, service, and innovation-applied across R&D, production, and aftermarket support.
- Standards & certifications: Adherence to international standards (e.g., CE certification for medical devices) to support export and institutional procurement.
- Public safety focus: Integration services and software development for public security command, control, and monitoring systems.
- Defense contribution: Production of military electronics such as infrared detectors and power supply systems for defense customers.
- Healthcare impact: Advanced medical devices and engineering services aimed at improving clinical care and hospital infrastructure.
Key operational channels through which Beijing Aerospace Changfeng makes money:
- Product sales - medical devices (diagnostic imaging, treatment equipment) and military electronics (sensors, power systems).
- Systems integration & software - public security platforms, surveillance and command systems, customized software services.
- Engineering & after-sales services - installation, maintenance contracts, calibration and certification services.
- Government and institutional contracts - procurement by defense, public security bureaus, and hospitals (tenders and long-term supply agreements).
- Export sales - CE-certified medical devices and defense/security products sold to selected overseas clients where allowed.
| Indicator | Value (Latest reported FY) | Notes |
|---|---|---|
| Stock ticker | 600855.SS | Shanghai Stock Exchange listing |
| Revenue (approx.) | RMB 1.20 billion | Company consolidated revenue (latest fiscal year) |
| Net profit (approx.) | RMB 120 million | Post-tax profit attributable to shareholders |
| Total assets | RMB 3.40 billion | Consolidated balance-sheet total |
| Market capitalization (approx.) | RMB 4.50 billion | At recent market prices |
| Major shareholder | State-affiliated aerospace holding (approx. 45%) | Controlling interest through holding companies |
| Free float / public shareholders | ~40% | Listed domestic and international institutional/retail investors |
| Institutional investors & funds | ~15% | Mutual funds, QFII/RQFII and specialized industry funds |
Business model drivers and revenue mix:
- High-margin defense electronics and proprietary sensor modules bolster gross margins relative to commodity manufacturing.
- Recurring service revenues from integration projects and maintenance contracts stabilize cash flow between hardware sales cycles.
- Certification-driven export opportunities (CE for medical devices) enable premium pricing and access to regulated markets.
- Government procurement cycles and strategic defense partnerships create multi-year contracts and barrier-to-entry advantages.
For further investor-focused context and shareholder composition details, see: Exploring Beijing Aerospace Changfeng Co.,Ltd Investor Profile: Who's Buying and Why?
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): Mission and Values
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) structures its operations across three principal business segments - Public Security, Military Electronics, and High‑End Medical Equipment - each supported by a nationwide marketing and after‑sales service network and targeted R&D investments to drive product differentiation and recurring revenue.- Core mission: deliver reliable, technology‑driven systems for national security, public safety, and advanced healthcare.
- Values: technological innovation, product reliability, lifecycle support, and compliance with defense & medical standards.
- Public Security: systems integration, command & control software, video analytics, and citywide security platform deployments for police, transport, and municipal clients.
- Military Electronics: development and manufacture of infrared detectors, electro‑optical assemblies, and power supply systems for defense platforms and military customers.
- High‑End Medical Equipment: production and sales of anesthesia machines, ICU ventilators, operating tables, and surgical lamps for hospitals and surgical centers.
- Product sales: one‑off revenue from hardware (detectors, ventilators, anesthesia machines, etc.).
- Systems integration & software: project‑based contracting and recurring software maintenance/licenses for public security platforms.
- After‑sales & services: extended warranties, spare parts, maintenance contracts and field service that create recurring service revenue.
- Defense supply contracts: long‑term procurement agreements and approved supplier status with defense agencies, often with multi‑year deliveries.
- Marketing & distribution: regional sales offices and authorized dealers covering provincial and municipal buyers, plus direct government procurement channels.
- After‑sales service: certified service centers and trained field engineers for prompt on‑site maintenance, spare parts logistics, and remote software updates.
- Investment priorities: infrared detector sensitivity, power system miniaturization, medical device reliability and regulatory compliance (e.g., CFDA/NMPA standards).
- Collaborations: domestic defense research institutes, universities, and hospital clinical partners for validation and product iteration.
| Metric | FY2023 (approx.) | Notes |
|---|---|---|
| Total revenue | RMB 1.8 billion | Consolidated group revenue across all segments |
| Net profit | RMB 120 million | Post‑tax attributable profit (approx.) |
| R&D spend | RMB 85 million (≈4.7% of revenue) | Ongoing investment in detectors, power supplies, medical devices |
| Segment revenue mix | Public Security 40% / Military Electronics 35% / Medical 25% | Approximate percentage contribution to total revenue |
| Employees | ≈3,200 | Manufacturing, R&D and service personnel nationwide |
- Infrared detectors: higher ASPs (average selling prices) and margin profile versus commodity electronics; often sold under defense contracts with multi‑year delivery schedules.
- Security platform projects: lump‑sum integration contracts with lower margin on hardware but higher lifetime value from software maintenance and upgrades.
- Medical devices: competitive hospital tenders; margins influenced by certification costs and after‑sales service intensity (e.g., ventilator service & consumables).
| Coverage | Data |
|---|---|
| Regional sales offices | Provincial presence across >20 provinces/municipalities |
| Service centers | Over 60 certified service locations nationwide |
| Authorized dealers | Network of >150 channel partners (system integrators and medical distributors) |
- Deepening installed base monetization via software & service contracts.
- Upgrading product mix toward higher‑value infrared sensors and advanced medical devices.
- Cross‑selling between public security platforms and municipal healthcare projects leveraging existing government relationships.
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): How It Works
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) operates as a diversified technology and services group with core activities spanning medical devices, public security and software, military electronics, engineering services, and large-event security & emergency response. Its revenue model is multi-pronged, combining product sales, systems integration contracts, recurring service revenues, and project-based turnkey deliveries.- Primary product sales: anesthesia machines, ventilators, surgical equipment and consumables sold to hospitals, distributors and government procurement agencies.
- Systems integration & software: public security integration projects and bespoke software development for municipal and provincial agencies.
- Military electronics manufacturing: infrared detectors, ruggedized power supplies, RF modules and other defense-grade components sold via state contracts and primes.
- Engineering & maintenance services: medical engineering installation, calibration, after-sales maintenance contracts and training services for healthcare customers.
- Event security & emergency response: large-scale security control, surveillance deployment and emergency-response operations for major events and government-organized activities.
- Direct product sales generate immediate revenue at the point of delivery; higher-margin items include specialized anesthesia workstations and advanced ventilators.
- Integration projects are typically quoted as multi-quarter or multi-year contracts, with milestone-based billing and retention clauses.
- Defense product sales are often delivered under framework contracts with staged deliveries and acceptance testing, providing predictable multi-year revenue streams.
- Service revenues (maintenance, calibration, software updates) provide recurring income and improve lifetime value per customer.
- Event and emergency services are bid-based, often producing lump-sum contracts during peak seasons or major national events.
| Revenue Stream | Primary Customers | Monetization Method | Typical Contract Size / Unit Price (approx.) |
|---|---|---|---|
| Medical devices (anesthesia, ventilators, surgical) | Hospitals, healthcare groups, distributors | Direct sales, tenders, O&M bundles | Ventilators: ¥50,000-¥400,000 per unit; Anesthesia workstations: ¥200,000-¥1,200,000 |
| Public security integration & software | Municipal/provincial public security bureaus, transport authorities | Systems integration, license & development fees, maintenance | Project contracts: ¥2M-¥100M+ depending on scope |
| Military electronics (infrared detectors, power supplies) | Defense ministries, prime contractors | Framework orders, staged deliveries, acceptance-based billing | Contracts: ¥5M-¥200M+ per program; components ¥10k-¥200k each |
| Medical engineering & after-sales services | Hospitals, clinics | Service contracts, spare parts, training | Annual service contracts: ¥50k-¥2M |
| Large-event security & emergency response | Event organizers, government agencies | Bids for turnkey security and emergency response packages | Event contracts: ¥0.5M-¥50M per event |
- Product sales: gross margins vary by product - higher for specialized medical devices (often 25-40%) and lower for commodity components (10-20%).
- Integration & software: higher margin on repeated software licenses and maintenance (25-45%), while one-off integration work can be lower-margin due to customization.
- Defense contracts: margins depend on contract type and obligations; strategic/long-term programs often yield stable but moderate margins (15-30%).
- Services: recurring revenue from service contracts and consumables improves overall margin stability and lifetime customer value.
| Segment | Estimated % of Revenue | Estimated Revenue (¥ millions) |
|---|---|---|
| Medical devices | 38% | 456 |
| Public security & software | 22% | 264 |
| Military electronics | 20% | 240 |
| Medical engineering & services | 12% | 144 |
| Event security & emergency response | 8% | 96 |
| Total (illustrative) | 100% | 1,200 |
- Product innovation and approvals (medical device regulatory certifications) - enables premium pricing and market access.
- Winning public security tenders and expanding software-as-a-service offerings for recurring revenue.
- Securing multi-year defense procurement programs and qualifying as a supplier to major primes.
- Expanding service footprint in hospitals to convert installations into ongoing maintenance contracts.
- Leveraging experience in large-event security to capture high-margin turnkey projects.
Beijing Aerospace Changfeng Co.,Ltd (600855.SS): How It Makes Money
Beijing Aerospace Changfeng (600855.SS) generates revenue principally through design, manufacture and sale of clinical equipment (anesthesia machines, ventilators, operating tables, surgical lamps), plus a smaller but strategically important business in public security and military electronics. The firm leverages scale in China's hospital procurement channels, an expanding export footprint and ongoing R&D to convert technological capability into sales and margins.- Primary revenue drivers: anesthesia machines and ventilators for hospitals and clinics.
- Adjunct product lines: operating tables, surgical lamps and related OR equipment sold through distributor networks and direct institutional contracts.
- Strategic contracts: public security and military electronics sales to government and defense customers, often with higher margin and long-term procurement cycles.
- Export growth: accelerating shipments to ASEAN, Middle East and select African markets to diversify revenue beyond domestic sales.
| Metric (FY/Annual) | Latest Reported / Approx. |
|---|---|
| Estimated Revenue (FY2023) | CNY 3.1 billion (approx.) |
| Estimated Net Profit (FY2023) | CNY 250 million (approx.) |
| Net Profit Margin | ~8% (approx.) |
| R&D Spending (% of revenue) | ~6% (CNY ~186 million) |
| Domestic market share (anesthesia/ventilation segment) | Top 3-5 domestic players (market share ~10-15% in key segments) |
| Export proportion of revenue | ~10-15% and growing year-over-year |
- Leading domestic manufacturer: ASCF is recognized as a leading Chinese maker of anesthesia machines, ventilators, operating tables and surgical lamps, supplying large public hospital tenders and private chains.
- Strong domestic presence: majority of sales come from China, leveraging established distribution and after-sales networks.
- International expansion: export channels increasing; management targets double-digit CAGR in overseas sales over the medium term.
- Innovation-led growth: sustained R&D investment supports new product introductions (advanced ventilators, integrated anesthesia workstations) and drives premium pricing.
- Alignment with national priorities: product lines in public security and military electronics complement civil healthcare business and can benefit from government procurement cycles and policy support.
- Competitive pressures: faces intense competition from domestic rivals (larger state-owned and private medical device firms) and global incumbents; competitive edge rests on deep domestic relationships, localized service and cost-competitive manufacturing.
- Product sales: direct sale of capital equipment to hospitals and clinics is the bulk of revenue; recurring revenue from consumables, maintenance contracts and software/service upgrades.
- After-sales services: maintenance & service contracts (multi-year), spare parts and consumables increase lifetime value per unit and stabilize margins.
- R&D commercialization: internal R&D programs aim to convert new platforms into exports and higher-margin product families.
- Government and institutional contracts: public security & defense electronics provide episodic but often high-value contracts that support revenue visibility.
| Segment | % of Revenue | Notes |
|---|---|---|
| Anesthesia machines & ventilators | 55% | Core clinical products, highest unit volumes and service attach rates |
| Operating tables & surgical lamps | 25% | OR equipment sold via hospital tenders and distributor channels |
| Public security & military electronics | 15% | Higher margin, procurement-timed sales |
| Exports & other | 5% | Growing focus-EMEA/ASEAN markets |
- Opportunities: expanded hospital capital spending, aging population-driven demand for advanced devices, premium product adoption in tier-2/3 cities, and export expansion.
- Risks: pricing pressure from large international suppliers, procurement concentration in public tenders, foreign-exchange volatility affecting export margins, and the need to sustain R&D to defend technology leadership.
Beijing Aerospace Changfeng Co.,Ltd (600855.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.